FORT LAUDERDALE, Fla., July 27, 2017 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc., (OTCQX:OMCM), a leading global provider of clinical data management technology, announces the 10-year anniversary of OmniComm Europe GmbH, the European headquarters of the parent company.
Earlier this year, OmniComm Systems — launched in Florida during early 1997 — celebrated 20 years of growth and innovation. During the last two decades, OmniComm has developed into a leading global provider of clinical data management technology. The company has gained a greater foothold in Europe and Asia in recent years, comprising approximately 20% of its annual revenue, in large part due to the local support from its European headquarters and additional European and Asian offices.
From its launch in July 2007, OmniComm Europe GmbH has grown from a staff of two people in Bonn, Germany to a team of 18 with more than 210 years of combined industry experience. The European headquarters offer expertise in clinical operations, EDC trial build, quality assurance, development, customized solutions, and a multi-lingual helpdesk and training services. OmniComm has additional European offices in the United Kingdom, The Netherlands and Spain.
“We are very excited about our 10-year track record of organic growth and continuous expansion of our market presence in the region,” said Yvonne Rollinger, Ph.D., managing director of OmniComm Europe GmbH. “We have achieved this milestone through the hard work of our team of industry professionals, who are passionate about delivering exceptional service and support. Seeing the trustful and long-lasting relationships with our clients and partners is a moment of pride and satisfaction for the entire team.”
OmniComm Europe GmbH mainly serves European clients, but also U.S.- and Asia-based trials with international investigative sites. Clients include biopharma and medical device companies, CROs and academic medical centers.
“We are extremely pleased with the recent success we’ve had across all of our product lines internationally,” said Stephen Johnson, president and CEO of OmniComm Systems. “We’ve experienced a steady 25% compound annual growth rate (CAGR) over the last 10 years. Sales in Europe have doubled in the last two years alone.”
Supporting Information
- Gustave Roussy Signs Five-Year Commitment for OmniComm’s TrialMaster® EDC to Support Cancer Research
- OmniComm Systems Wins $11.7 Million TrialOne Contract With Global Contract Research Organization
- OmniComm Systems Signs Fifth TrialOne Contract in China in Four Months
- OmniComm Systems, Inc. Reports Financial Results for the Year Ended December 31, 2016. Record Revenue and Operating Income
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 5,000 clinical trials. For more information, please visit: omnicomm.com
Trademarks
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.